相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Dietrich A. Ruess et al.
NATURE MEDICINE (2018)
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
Gabrielle S. Wong et al.
NATURE MEDICINE (2018)
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
Sara Mainardi et al.
NATURE MEDICINE (2018)
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1-and RAS-driven cancers
Robert J. Nichols et al.
NATURE CELL BIOLOGY (2018)
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
Carmine Fedele et al.
CANCER DISCOVERY (2018)
Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma
Jiawei Zheng et al.
TUMOR BIOLOGY (2016)
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen et al.
NATURE (2016)
Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation
Jian Zheng et al.
NATURE GENETICS (2016)
New structural and functional insight into the regulation of Ras
Yoshihito Kano et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding
Pamela Y. Ting et al.
FASEB JOURNAL (2015)
Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
John C. Hunter et al.
MOLECULAR CANCER RESEARCH (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Susan K. Fetics et al.
STRUCTURE (2015)
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
Severa Bunda et al.
NATURE COMMUNICATIONS (2015)
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Woonghee Lee et al.
BIOINFORMATICS (2015)
Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
Li-Fan Zeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Integrated RAS signaling defined by parallel NMR detection of effectors and regulators
Matthew J. Smith et al.
NATURE CHEMICAL BIOLOGY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation
Severa Bunda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic Leukemia
Severa Bunda et al.
CANCER RESEARCH (2013)
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies
Aung Naing et al.
INVESTIGATIONAL NEW DRUGS (2013)
NMR-based functional profiling of RASopathies and oncogenic RAS mutations
Matthew J. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cell signaling, post-translational protein modifications and NMR spectroscopy
Francois-Xavier Theillet et al.
JOURNAL OF BIOMOLECULAR NMR (2012)
Probing the GTPase cycle with real-time NMR: GAP and GEF activities in cell extracts
Christopher B. Marshall et al.
METHODS (2012)
Modified SH2 domain to phototrap and identify phosphotyrosine proteins from subcellular sites within cells
Akiyoshi Uezu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
Siyuan Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo
Yi Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2
Jun-Ho Ahn et al.
CANCER LETTERS (2011)
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
Natsuko Suwaki et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
John J. Arcaroli et al.
CLINICAL CANCER RESEARCH (2010)
Tyr39 of Ran Preserves the Ran.GTP Gradient by Inhibiting GTP Hydrolysis
Sven Brucker et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Identification of c-Src as a Potential Therapeutic Target for Gastric Cancer and of MET Activation as a Cause of Resistance to c-Src Inhibition
Wataru Okamoto et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Nagathihalli S. Nagaraj et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Allosteric modulation of Ras positions Q61 for a direct role in catalysis
Greg Buhrman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Dominico Vigil et al.
NATURE REVIEWS CANCER (2010)
Combined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant Tumors
Yi Chen et al.
CLINICAL CANCER RESEARCH (2009)
Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE
Eiji Kinoshita et al.
NATURE PROTOCOLS (2009)
Characterization of the Intrinsic and TSC2-GAP-Regulated GTPase Activity of Rheb by Real-Time NMR
Christopher B. Marshall et al.
SCIENCE SIGNALING (2009)
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
Marie Dance et al.
CELLULAR SIGNALLING (2008)
The role of Shp2 (PTPN11) in cancer
M. Golam Mohi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Structure of a transient intermediate for GTP hydrolysis by Ras
B Ford et al.
STRUCTURE (2006)
High yield bacterial expression of active c-Abl and c-Src tyrosine kinases
MA Seeliger et al.
PROTEIN SCIENCE (2005)
A novel role for Gab1 and SHP2 in epidermal growth factor-induced ras activation
A Montagner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural analysis of autoinhibition in the Ras activator son of sevenless
H Sondermann et al.
CELL (2004)
Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor sprouty
H Hanafusa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tyrosine phosphorylation of the Rab24 GTPase in cultured mammalian cells
J Ding et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase
S Tu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
YM Agazie et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The chloroplast import receptor Toc34 functions as preprotein-regulated GTPase
M Jelic et al.
BIOLOGICAL CHEMISTRY (2002)
The structural basis for the transition from Ras-GTP to Ras-GDP
BE Hall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Activated Src oncogene phosphorylates R-Ras and suppresses integrin activity
JX Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange
BE Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Toc34 is a preprotein receptor regulated by GTP and phosphorylation
N Sveshnikova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
